New MRI scan could replace invasive heart test for lung pressure patients
NCT ID NCT03928002
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a special MRI scan (4D Flow) can accurately measure blood flow to the lungs in people with both congenital heart disease and pulmonary hypertension. The standard test for this is a heart catheterization, which is invasive and uncomfortable. The study involved 50 patients aged 7 and older. Researchers compared the MRI results to the catheterization results to see if the MRI could be a reliable, non-invasive alternative for monitoring these patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CONGENITAL HEART DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
centre chirurgical Marie Lannelongue
Le Plessis-Robinson, 92350, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart surgery in childhood: a hidden impact on speech and memory?
- A website designed to steer teens with heart defects away from vaping
- AI stethoscope aims to spot hidden heart and lung problems in children
- Can a new pill ease the strain of pulmonary arterial hypertension?
- Could a gut bacteria transplant ease a rare lung disease?
- Can community hospitals in zambia master severe disease care?